Biomineralized DNA nanospheres by metal organic framework for enhanced chemodynamic therapy

Chemodynamic therapy (CDT) has emerged as an innovative treatment strategy for cancer therapy, and yet most of current systems are highly dependent on endogenous H2O2 for hydroxyl radical (?OH) generation, leading to limited therapeutic efficacy. Therefore, it is of significant importance to develop CDT agents with efficient H2O2 self-supplying ability for enhanced CDT efficacy. Herein, we report metal organic framework (MOF)-biomineralized DNA nanospheres as CDT agent engineered with tumor-activable cascade reactions for boosting the intracellular H2O2 concentration, thus achieving remarkable antitumor outcome. As a result of tumor acidinduced dissociation of CDT agent, the released Fe2+/Fe3+ triggers Fenton reaction to produce ?OH and the released GOx enables to catalyze glucose into H2O2, which synergistically elevates the ROS level in tumor cells and induces ferroptosis. By exploitation of tumor acid-activable cascade reactions for supplying sufficient H2O2, our CDT agent achieves prominent therapeutic efficacy in both in vitro and in vivo assays. Our work provides a promising strategy to develop CDT agents for improved CDT efficacy.

Automated summary

In this study, metal organic framework (MOF)-biomineralized DNA nanospheres were developed as chemodynamic therapy (CDT) agents with tumor-activable cascade reactions for boosting intracellular H2O2 concentration, achieving remarkable antitumor outcome. The CDT agent utilizes tumor acid-induced dissociation to release Fe2+/Fe3+ for Fenton reaction and GOx for catalyzing glucose into H2O2, synergistically elevating ROS level in tumor cells to induce ferroptosis. This strategy provides a promising approach for developing CDT agents with improved therapeutic efficacy.